๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Kinetics of sulfamethylthiadiazole acetylation and excretion in humans

โœ Scribed by Eino Nelson; Inge O'Reilly


Publisher
John Wiley and Sons
Year
1961
Tongue
English
Weight
333 KB
Volume
50
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

โœฆ Synopsis


In studying the postabsorptive and postequilibrative phases of sulfamethylthiadiazole excretion and acetylation in humans, it was found that urinary excretion of unchanged drug and its acetylation could be described by competitive first-order p c e s s e s . The excretion of acetylated drug was also by a first-order process that ollowed its first-order acetylation. The mean half-life for excretion of unchanged drug was about one and one-half hours, for formation of acetylated drug about fifteen hours, and for excretion of acetylated drug about one-half hour. Experimental values of excretion were in excellent agreement with values predicted by equations previously developed to describe the kinetic model found to hold in the present work.

T WAS RECENTLY reported that the acetylation


๐Ÿ“œ SIMILAR VOLUMES


Acetylation of sulfamethylthiadiazole
โœ Shun-Ichi Naito; Eino Nelson ๐Ÿ“‚ Article ๐Ÿ“… 1963 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 118 KB
Biliary excretion of chlorthalidone in h
โœ H. L. J. Fleuren; C. P. W. Verwey-Van Wissen; Th. A. Thien ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 415 KB ๐Ÿ‘ 2 views

## Abstract A single oral dose of the diuretic chlorthalidone (100 or 200 mg) was given to six cholecystectomized patients with Tโ€tube drainage of the common bile duct, and the 24 h bile and urine were collected during 3โ€“7 days. Urinary recovery of chlorthalidone was 23โ€“27 per cent of the dose, whi

Urinary excretion of dyphylline in human
โœ Keith J. Simons; F. Estelle R. Simons ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 351 KB ๐Ÿ‘ 1 views
Pharmacokinetics and acetylation of sulf
โœ Tom B. Vree; Eleonora W. J. Beneken Kolmer; Yechiel A. Hekster; Minoru Shimoda; ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 604 KB

In humans sulfa-2-monomethoxine (S) is metabolized by N,-acetylation (39.9 f 8.0 per cent). After an oral dose, S is eliminated biphasically (t%, 5.2 f 1.6 h and 13.2 f 3.4h) which is similar in both fast and slow acetylators. The metabolite N,-acetylsulfa-2monomethoxine (N, ) is eliminated monophas